Track topics on Twitter Track topics that are important to you
AHF calls on the Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, and Deputy Director-General of Emergency Preparedness and Response, Dr. Peter Salama, to expedite delivery of Ebola vaccine to Democratic Republic of Congo (DRC), where latest outbreak has claimed 27 lives to date. Ebola is back and the world is...
There are challenges ahead in the real-world use of the Ebola vaccine the DRC, warned the head of the global health organization that is funding the current vaccination effort.
Allergy Therapeutics has obtained positive Phase II results for its grass pollen allergy vaccine and plans to launch a Phase III study next year. British biotech Allergy Therapeutics has obtained positive Phase II results for its grass pollen allergy vaccine. ... The post Grass Pollen Allergy Vaccine Gets Encouraging Phase II Results appeared first on Labiotech.eu.
A total of 27 people have died since April, but new funds and the deployment of an experimental vaccine are expected to help contain the virus.
May 23, 2018 (Investorideas.com Newswire) Ram Selvaraju, an analyst with H.C. Wainwright & Co., explained the recently released data from a study of one of this immunotherapy firm's therapeutics.
Study Finds Prevnar 13 was Associated With Reduced Risk of Hospitalization From Vaccine-Type Community-Acquired Pneumonia in Older Adults1 Pfizer Inc. (NYSE: PFE) announced today that results from a study analyzing real-world effectiveness data found that Prevnar 13® (pneumococcal 13-valent conjugate vaccine [diphtheria CRM197 Protein]) reduced...
RSV affects 33 million children globally and leads to approximately 120,000 childhood deaths every year1 In the United States approximately 177,000 older adults are hospitalized annually because of RSV2 The clinical program aims to develop a vaccine for populations at highest risk of infection: infants through maternal immunization, and ...
The Ebola vaccine being fielded in the latest outbreak is the product of years of striving against skepticism and disinterest.
The American Academy of Pediatrics said on Monday that it will recommend the injectable influenza vaccine over the live attenuated flu vaccine (nasal spray marketed...
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: ImmusanT goes on hiring spree ahead of phase 2 celiac vaccine trial .ImmusanT is boosting its senior staff, bringing on Daiichi Sankyo’s SVP for internal medicine therapeutics, Ken … Continue reading → Cet article #news #biotech ImmusanT goes on hiring spree ahea...
The post NIH Awards Grant to Lumen Bioscience for Cost-Effective Oral Malaria Vaccine appeared first on SynBioBeta.
GC Pharma, IDRI and MIBR Bringing Together to Develop Innovative Vaccines YONGIN, South Korea, May 20, 2018 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced the establishment of Curevo Inc. ("Curevo"). The newly established Seattle-based company's goal...
As another HIV Vaccine Awareness Day slides by on the calendar, there is still no cure for the disease. However, many pharma and biotech companies are desperately working on developing therapeutics for the devastating disease.
Take a peek at some of the latest, greatest content from NEJM Group: NEJM Primary Care/Hospitalist Page: Case record: An 83-year-old woman...
Provider persistence in explaining vaccine rationale to parents was the most effective approach to achieving same-day HPV vaccination.
As a leading supplier of products and services in antibody development, immunoassay and diagnosis, Creative Diagnostics announces that it has added Magic™ adjuvant to its existing products portfolio. The Magic™ adjuvants are highly efficient, biocompatible, convenient and economical, which have become the gold standard references for any immunization experiments....
Mandated influenza vaccination programs for healthcare workers have proved highly effective at raising immunization rates, but hospitals that fail to navigate religious exemptions have found themselves on the wrong end of court rulings.
One of the great pandemics in human history has been fought to a near draw, with no vaccine in sight but treatments that dramatically extend life and block transmission to others.
The 2017/2018 influenza season was considered one of the worst, made more so by the ineffectiveness of the season’s flu vaccine. The FDA is focusing partially on simply determining why this year’s flu vaccine missed the mark.
COPENHAGEN, Denmark - May 16, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) will announce its 2018 first quarter results on Thursday, May 24, 2018. The management of Bavarian Nordic will host a conference call at 2:00 pm CEST (8:00 am EDT) on the same day to present the interim results followed by a Q&A session. A live and replay version of the call and relevant slides will...
TPIV200 stimulates T cells to attack ovarian and triple negative breast tumor cells that over-express the folate receptor alpha protein.
—Investigational vaccine designed to generate broad and durable immune protection over multiple influenza seasons— —Subjects challenged with influenza virus genetically drifted by six years from vaccine strain— —Study supported by U.S. Department of Defense— FluGen, Inc. announced today that the first subject has...